申请人:CoMentis, Inc.
公开号:US20150225386A1
公开(公告)日:2015-08-13
The present invention provides a hydrate of N-[(4S)-2-amino-2′,2′-dimethyldispiro[1,3-oxazole-4,4′-chromene-3′,3″-oxetan]-6′-yl]-5-chloropyridine-2-carboxamide which is useful as an active ingredient of a pharmaceutical composition, in particular, a pharmaceutical composition for preventing or treating diseases or conditions associated with and/or mediated by β-secretase activity, hydrolysis of a β-secretase site of a β-amyloid precursor protein, and/or β-amyloid protein accumulation, including a pharmaceutical composition for preventing or treating diseases including, but not limited to, Glaucoma, MCI (Mild cognitive impairment) or Alzheimer's disease, especially, Alzheimer's disease.
本发明提供了一种N-[(4S)-2-氨基-2′,2′-二甲基二螺并[1,3-噁唑-4,4′-色烯-3′,3″-氧杂环辛]-6′-基]-5-氯吡啶-2-羧酰胺的水合物,其作为药物组成物的活性成分非常有用,特别是用于预防或治疗与/或介导β-分泌酶活性、β-淀粉样前体蛋白的β-分泌酶位点的水解以及/或β-淀粉样蛋白的积累有关的疾病或症状的药物组成物,包括预防或治疗包括但不限于青光眼、轻度认知障碍或阿尔茨海默病等疾病的药物组成物,特别是阿尔茨海默病。